EUVIMEDEUVIMED entdecken
Crossref

Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging

Jolien Perneel, Manuela Neumann, Bavo Heeman, Simon Cheung, Marleen Van den Broeck, Sarah Wynants, Matt Baker, Cristina T Vicente, Júlia Faura, Rosa Rademakers, Ian R A Mackenzie iD

Acta Neuropathologica · 2023-03 · 145 (3) · 285-302

DOI: 10.1007/s00401-022-02531-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 17.12.2022. Verfasst von Jolien Perneel und 10 weiteren Autor:innen. Beteiligte Einrichtung: VIB Center for Molecular Neurology, VIB, Antwerp, Belgium. Hauptthemen laut MEDLINE: Frontotemporal Dementia, Neurodegenerative Diseases, Frontotemporal Lobar Degeneration. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: CIHR, NIH HHS, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several studies using cryogenic electron microscopy (cryo-EM) techniques recently reported the isolation and characterization of novel protein filaments, composed of a C-terminal fragment (CTF) of the endolysosomal transmembrane protein 106B (TMEM106B), from human post-mortem brain tissue with various neurodegenerative conditions and normal aging. Genetic variation in TMEM106B is known to influence the risk and presentation of several neurodegenerative diseases, especially frontotemporal dementia (FTD) caused by mutations in the progranulin gene (GRN). To further elucidate the significance of TMEM106B CTF, we performed immunohistochemistry with antibodies directed against epitopes within the filament-forming C-terminal region of TMEM106B. Accumulation of TMEM106B C-terminal immunoreactive (TMEM-ir) material was a common finding in all the conditions evaluated, including frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP), Alzheimer's disease, tauopathies, synucleinopathies and neurologically normal aging. TMEM-ir material was present in a wide range of brain cell types and in a broad neuroanatomical distribution; however, there was no co-localization of TMEM-ir material with other neurodegenerative proteins in cellular inclusions. In most conditions, the presence and abundance of TMEM-ir aggregates correlated strongly with patient age and showed only a weak correlation with the TMEM106B haplotype or the primary pathological diagnosis. However, all patients with FTD caused by GRN mutations were found to have high levels of TMEM-ir material, including several who were relatively young (< 60 years). These findings suggest that the accumulation of TMEM106B CTF is a common age-related phenomenon, which may reflect lysosomal dysfunction. Although its significance in most neurodegenerative conditions remains uncertain, the consistent finding of extensive TMEM-ir material in cases of FTLD-TDP with GRN mutations further supports a pathomechanistic role of TMEM106B and lysosomal dysfunction in this specific disease population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Frontotemporal DementiaNeurodegenerative DiseasesFrontotemporal Lobar DegenerationHumansIntercellular Signaling Peptides and ProteinsMembrane ProteinsNerve Tissue ProteinsAging

Stichwörter der Autor:innen

FTLD-TDPFrontotemporal dementiaGRNNeurodegenerative diseaseTMEM106B

Substanzen

Intercellular Signaling Peptides and ProteinsMembrane ProteinsNerve Tissue ProteinsTMEM106B protein, human

Autor:innen und Institutionen

  • VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Department of Neuropathology, University of Tübingen, Tübingen, Germany.
  • Molecular Neuropathology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, Tübingen, Germany.
  • Department of Pathology, Vancouver Coastal Health, Vancouver, BC, Canada.
  • Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.

ORCID-Profile: Ian R A Mackenzie

Förderung

  • CIHR
  • NIH HHS
  • Canadian Institutes of Health Research
  • National Institutes of Health
  • Universiteit Antwerpen
  • Vlaams Instituut voor Biotechnologie
  • Flanders Research Foundation
  • Association for Frontotemporal Degeneration

Zitieren

APA

Perneel, J., Neumann, M., Heeman, B., Cheung, S., Van den Broeck, M., Wynants, S., Baker, M., Vicente, C. T., Faura, J., Rademakers, R., & Mackenzie, I. R. A. (2023). Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging. Acta Neuropathologica, 145(3), 285-302. https://doi.org/10.1007/s00401-022-02531-3

Vancouver

Perneel J, Neumann M, Heeman B, Cheung S, Van den Broeck M, Wynants S, et al. Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging. Acta Neuropathologica. 2023;145(3):285-302. doi:10.1007/s00401-022-02531-3

BibTeX
@article{Perneel2023,
  author = {Perneel, Jolien and Neumann, Manuela and Heeman, Bavo and Cheung, Simon and Van den Broeck, Marleen and Wynants, Sarah and Baker, Matt and Vicente, Cristina T and Faura, Júlia and Rademakers, Rosa and Mackenzie, Ian R A},
  title = {Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging},
  journal = {Acta Neuropathologica},
  year = {2023},
  volume = {145},
  number = {3},
  pages = {285--302},
  doi = {10.1007/s00401-022-02531-3}
}
Kostenlos starten →